Funding and portfolio disposal
Two raisings provided A$3.052m gross. The Slate Dam/Trojan and Clinker Hills disposal generated A$0.500m cash consideration, distinct from an accounting gain.
Aruma’s cash and equity record shows an exploration company funding work and portfolio changes rather than generating mine sales. The latest year brought new copper and uranium exposure, further equity funding and continued cash consumption.
Reading the figures: Units are stated by table or metric. Brackets denote negative amounts. Supported nil is zero; unlike reporting bases remain separately labelled.
Before any later funding.
Statutory, excluding other comprehensive expense.
Includes exploration cash expenditure.
Consolidated accounting equity.
The early portfolio emphasised Western Australian gold and lithium exploration. The NHM transaction subsequently added copper and uranium tenements in Queensland and South Australia. A portfolio transaction is not a commercial mine start-up.
Equity funding replenished cash in FY2022, followed by three lower year-end cash balances. This is an exploration funding cycle, not a mine-sales growth series. Exploration expense and exploration cash payments measure different things.
Two raisings provided A$3.052m gross. The Slate Dam/Trojan and Clinker Hills disposal generated A$0.500m cash consideration, distinct from an accounting gain.
Two placements raised A$4.660m before issue costs; the company also received a A$0.459m R&D tax incentive. These funded exploration and working capital rather than mine production.
FY2024 comparative statements record A$2.512m exploration expense and A$3.522m operating cash outflow for FY2023; neither is a capitalised resource valuation.
The copper and uranium transaction was announced in May 2024. Shareholder approval on 1 August falls in FY2025, rather than proving completion before June.
The NHM acquisition used settlement shares and milestone options. A separate A$0.900m placement funded the company; Piper maiden drilling began after year end.
Cash and equity rose in the placement-funded FY2022 year, then declined through FY2025 as exploration and overheads continued. Accounting equity is not a mineral resource valuation.
A$ million
AI-generated presentation · values from Cash and equity over five balance dates; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Cash and equity over five balance dates; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 2.692 | 4.701 | 3.155 | 2.144 | 0.861 |
| Consolidated total equity | 2.706 | 4.259 | 3.286 | 2.250 | 1.961 |
FY2022 is established from the opening FY2023 cash/equity values in the FY2024 report: 1 July 2022 balances correspond to the preceding 30 June. FY2023 uses the same company’s FY2024 comparatives, not the foreign-company FY2023 slice.
A bounded check of Aruma’s own FY2022 parsed financial statements also corroborates cash A$4,701,408 and equity A$4,259,327. Foreign-company tables linked to that document were not used.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The accounting policy expenses ongoing exploration but capitalises licence acquisition costs. The new exploration asset balance and current-year exploration expense therefore measure different activities. The latest loss cannot be described as simply cash used or investment capitalised.
A$ million
AI-generated presentation · values from Exploration expenses and statutory loss; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Exploration expenses and statutory loss; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Other income | 0.238 | 0.459 | 0.837 | 1.146 | 0.425 |
| Exploration expense | (0.887) | (1.887) | (2.512) | (0.941) | (1.184) |
| Statutory net loss | (1.596) | (3.242) | (3.045) | (1.126) | (2.103) |
FY2025 statutory income lines use correction decisions already saved on 24 September 2026. Loss excludes other comprehensive expense; the two are not interchangeable.
FY2021 lease-disposal proceeds/gain are not recurring mineral sales, and are not merged into an operating-revenue growth chart. The extraction contains conflicting disposal-gain presentations, so no synthetic revenue trend is constructed.
FY2022 was recovered from Aruma’s existing parsed consolidated statements. Exploration expense A$1,886,652 is not the A$1,557,768 exploration cash payment. Net loss is distinct from total comprehensive loss.
Source: Annual extractions plus the bounded Aruma FY2022 parsed-statement recovery; editions listed once below.
Equity cash receipts and the R&D tax incentive provided funding, but exploration and supplier payments continued. Cash-flow issue costs exclude non-cash option transfers inside equity. The directors and auditor identified a material going-concern uncertainty dependent on further capital.
A$ million
AI-generated presentation · values from Cash movement: supported annual observations; no missing values plotted as zero.
A$ million
AI-generated presentation · values from FY2025 operating and funding components; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | (1.793) | (2.309) | (3.522) | (0.984) | (2.095) |
| Net financing cash flow | 2.850 | 4.338 | 2.075 | (0.019) | 0.814 |
FY2022 uses the consolidated cash-flow statement: operating outflow A$2,309,149 and financing inflow A$4,338,216. The operating reconciliation differs by A$1 (A$2,309,148); the statement is retained. FY2024 similarly retains the statement A$983,657 rather than the reconciliation A$983,654.
FY2025 cash decreased despite A$0.900m gross equity receipts; net financing was lower after cash issue costs and lease repayments.
Source: Annual extractions plus the bounded Aruma FY2022 parsed-statement recovery; editions listed once below.
A$ million
| Metric | FY2025 |
|---|---|
| R&D tax incentive receipts | 0.415 |
| Exploration cash expenditure | (1.179) |
| Supplier and employee payments | (1.385) |
| Gross equity cash receipts | 0.900 |
| Cash issue costs | (0.080) |
| Lease repayments | (0.006) |
Selected components, not a full cash reconciliation. Lead-manager option accounting is non-cash: total share-capital transaction costs should not replace the cash-flow statement’s A$80,261 cash issue costs.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
NHM consideration included settlement shares valued at A$477,000 and milestone options valued at A$510,300. These non-cash amounts should not be counted as placement cash. The reported A$50,000 initial deposit is separately described, not silently added to the latest cash-flow categories.
FY2025 current liabilities were modest relative to current assets, but that does not eliminate the need to finance future exploration. An end-date liquidity comparison is not a forecast of funding sufficiency.
A$ million
| Metric | FY2025 |
|---|---|
| Cash and equivalents | 0.861 |
| Term-deposit investments | 0.071 |
| Current assets | 1.015 |
| Current liabilities | 0.128 |
| Capitalised exploration assets | 1.037 |
| Total assets | 2.089 |
| Total liabilities | 0.128 |
The term deposit is a separate reported asset; unrestricted availability is not assumed. Acquisition costs can be capitalised while ongoing exploration is expensed. The deposit, cash and asset subtotals are not additive categories.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared from the existing year-by-year extractions and saved corrections, supplemented by a specifically authorised DB-table and existing parsed-text lookup for residual issues on 28 September 2026. No PDFs were downloaded or reparsed and no financial web research was used. The lookup log and source locators are retained; this is not an independent audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.